SAN MATEO, Calif., May 15 /PRNewswire-FirstCall/ -- NeurogesX, Inc.
(Nasdaq: NGSX), a biopharmaceutical company focused on developing novel
pain management therapies, announced today that it is scheduled to present
on Monday, May 19, 2008 at the Rodman & Renshaw 5th Annual Global
Healthcare Conference. Anthony DiTonno, President and Chief Executive
Officer, will be presenting and Stephen Ghiglieri, Chief Financial Officer,
will be available to respond to questions.
Event: Rodman & Renshaw 5th Annual Global Healthcare Conference
Date: Monday, May 19, 2008
Time: 5:15 p.m. CEST
Place: Le Meridien Beach Plaza Hotel, Monte Carlo, Monaco
An audio Web cast of the Company's presentations will be available by going to the investor relations section of NeurogesX' Web site at http://www.neurogesx.com. A replay of the presentation will be available for 15 days.
About NeurogesX, Inc.
NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on
developing novel pain management therapies. Its initial focus is on chronic
peripheral neuropathic pain, including postherpetic neuralgia (PHN),
painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic
neuropathy (PDN). NeurogesX' late stage product portfolio is led by its
product candidate NGX-4010, a dermal patch designed to manage pain
associated with peripheral neuropathic pain conditions, that the company
believes offers significant advantages over other pain
|SOURCE NeurogesX, Inc.|
Copyright©2008 PR Newswire.
All rights reserved